Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

被引：0
|
作者：
Vaz, Maria Angeles
Girones, Regina
Del Barco, Sonia
Sanchez, Juan Manuel Sepulveda
Alonso, Miriam
Pineda, Estela
Balana, Carmen
Martinez-Garcia, Maria
机构：
[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[2] Hosp Univ & Politecn La Fe, Med Oncol Serv, Valencia, Spain
[3] Inst Catal Oncol Girona, Med Oncol Serv, Girona, Spain
[4] Hosp Univ 12 Octubre, Med Oncol Serv, Madrid, Spain
[5] Hosp Virgen Rocio, Med Oncol Serv, Seville, Spain
[6] Hosp Clin Barcelona, Med Oncol Serv, Barcelona, Spain
[7] Inst Catal Oncol, Med Oncol Serv, Badalona, Spain
[8] Hosp Mar, Med Oncol Serv, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2060
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [2] Final results of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Salgado, M. A. Vaz
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    Lopez-Munoz, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S410 - S410
  • [3] Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial
    Martinez-Garcia, Maria
    Velasco, Guillermo
    Pineda, Estela
    Gil-Gil, Miguel
    Alameda, Francesc
    Capellades, Jaume
    Martin-Soberon, Mari Cruz
    Lopez-Valero, Israel
    Tovar Ambel, Elena
    Foro, Palmira
    Taus, Alvaro
    Arumi, Montserrat
    Hernandez-Lain, Aurelio
    Sepulveda-Sanchez, Juan Manuel
    CANCERS, 2022, 14 (10)
  • [4] GEINO 1402: A phase Ib dose-escalation study followed by an extension phase to evaluate safety and efficacy of crizotinib in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma (GB)
    Martinez Garcia, M.
    Gil, M. J.
    Pineda, E.
    Martin Soberon, M. C.
    Mesia Barroso, C.
    Foro, P.
    Capellades, J.
    Sarmiento, B.
    Bruna, J.
    Verger, E.
    Taus Garcia, A.
    Alameda, F.
    Hernandez Lain, A.
    Velasco, G.
    Sepulveda Sanchez, J. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 147 - 147
  • [5] Tetrahydrocannabinol (THC) / cannabidiol (CBD) oral solution in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma: Phase Ib GEINO-1601 trial
    Sepulveda, J. M.
    Alonso, M.
    Velilla, G.
    Garcia Grove, C.
    Martinez-Garcia, M.
    Foro, P.
    Garcia Gonzalez, C.
    Muriel Lopez, C.
    Luque, R.
    Luque, N.
    Stradella, A.
    Sabat Viltro, P.
    Navarro Martin, M.
    Rivas Lopez, B.
    Guzman, M.
    Tovar-Ambel, E.
    Velasco, G.
    Sanchez Morillas, R.
    Fuster Salva, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S411 - S411
  • [6] A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
    Werlenius, Katja
    Stragliotto, Giuseppe
    Strandeus, Michael
    Blomstrand, Malin
    Caren, Helena
    Jakola, Asgeir S.
    Rydenhag, Bertil
    Dyregaard, Dorte
    Dzhandzhugazyan, Karine N.
    Kirkin, Alexei F.
    Raida, Martin K.
    Smits, Anja
    Kinhult, Sara
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [7] Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
    Compter, Inge
    Eekers, Danielle B. P.
    Hoeben, Ann
    Rouschop, Kasper M. A.
    Reymen, Bart
    Ackermans, Linda
    Beckervordersantforth, Jan
    Bauer, Noel J. C.
    Anten, Monique M.
    Wesseling, Pieter
    Postma, Alida A.
    De Ruysscher, Dirk
    Lambin, Philippe
    AUTOPHAGY, 2021, 17 (09) : 2604 - 2612
  • [8] Safety of idroxioleic acid in combination with standard of care (temozolomide and/or radiation therapy) in newly diagnosed glioblastoma patients: A phase Ib trial
    Balana, C.
    del Barco Berron, S.
    Stradella, A.
    Villanueva Vazquez, R.
    Cuesta, A.
    Torres, J. V.
    Roma, J.
    Taylor, R.
    Escriba, P. V.
    Llobet, E.
    McNicholl, A. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S518 - S518
  • [9] Azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II CAN-201 NDG trial design.
    Sepulveda, Jose Manuel
    Valiente, Manuel
    Vaz-Salgado, Maria Angeles
    Pineda, Estela
    Martinez-Garcia, Maria
    Vico, Maria Ruiz
    Velilla, Gabriel
    Mazariegos, Manuel Alejandro
    Valduvieco, Izaskun
    Castro-Henriques, Maria
    Cano, Laia
    Marcus, Stephen Garrett
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Early experience with azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II CAN-201 NDG trial
    Pineda, E.
    Sepulveda, J. M.
    Valiente, M.
    Vaz-Salgado, M. A.
    Martinez-Garcia, M.
    Ruiz Vico, M.
    Velilla, G.
    Mazariegos-Rubi, M. A.
    Valduvieco, I.
    Castro-Henriques, M.
    Cano, L.
    Marcus, S. G.
    ANNALS OF ONCOLOGY, 2024, 35 : S410 - S411
12345